Stryker (SYK) Share-based Compensation (2009 - 2026)
Stryker's (SYK) quarterly Share-based Compensation came in at $7.0 million in Q2 2026, down 78.12% year-over-year from $32.0 million in Q2 2025, and down 94.96% quarter-over-quarter from $139.0 million in Q1 2026.
Analysis
Stryker (SYK) Share-based Compensation (2009 - 2026) Analysis & Trends
Stryker (SYK) has reported Share-based Compensation for 18 consecutive years, with $7.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Share-based Compensation fell 78.12% year-over-year to $7.0 million in Q2 2026; TTM through Jun 2026 was $256.0 million, a 11.79% increase from a year earlier, with the FY2025 full-year figure at $243.0 million, up 6.11% from the prior year.
- Share-based Compensation was $7.0 million for Q2 2026 at Stryker, down from $139.0 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $139.0 million in Q1 2026 and troughed at $7.0 million in Q2 2026.
- A 5-year average of $55.1 million and a median of $46.5 million in 2024 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation soared 60.0% in 2025 and sank 78.12% in 2026, its largest moves.
- Over 5 years, Share-based Compensation stood at $28.0 million in 2022, then surged by 42.86% to $40.0 million in 2023, then climbed by 12.5% to $45.0 million in 2024, then rose by 6.67% to $48.0 million in 2025, then slumped by 85.42% to $7.0 million in 2026.
- The last three Share-based Compensation figures came in at $7.0 million (Q2 2026), $139.0 million (Q1 2026), and $48.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.41 Bn | 175.81 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Intuitive Surgical | 127.61 Bn | 122.40 Bn | 1.96 Bn | 67.10 Mn |
| 3 | Medtronic | 117.11 Bn | 108.30 Bn | 6.34 Bn | 125.00 Mn |
| 4 | Stryker | 105.11 Bn | 101.64 Bn | 4.50 Bn | 7.00 Mn |
| 5 | Boston Scientific | 64.50 Bn | 63.96 Bn | 3.85 Bn | 61.00 Mn |
| 6 | Edwards Lifesciences | 49.86 Bn | 45.61 Bn | 1.35 Bn | 42.20 Mn |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn | 42.00 Mn |
| 8 | Dexcom | 32.10 Bn | 30.16 Bn | 830.00 Mn | 39.00 Mn |
| 9 | Steris | 20.72 Bn | 20.24 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Zimmer Biomet Holdings | 17.77 Bn | 17.36 Bn | 1.54 Bn | 23.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.00 Mn |
| Mar 31, 2026 | 139.00 Mn |
| Dec 31, 2025 | 48.00 Mn |
| Sep 30, 2025 | 62.00 Mn |
| Jun 30, 2025 | 32.00 Mn |
| Mar 31, 2025 | 101.00 Mn |
| Dec 31, 2024 | 45.00 Mn |
| Sep 30, 2024 | 51.00 Mn |
| Jun 30, 2024 | 20.00 Mn |
| Mar 31, 2024 | 113.00 Mn |
| Dec 31, 2023 | 40.00 Mn |
| Sep 30, 2023 | 52.00 Mn |
| Jun 30, 2023 | 19.00 Mn |
| Mar 31, 2023 | 94.00 Mn |
| Dec 31, 2022 | 28.00 Mn |
| Sep 30, 2022 | 33.00 Mn |
| Jun 30, 2022 | 35.00 Mn |
| Mar 31, 2022 | 72.00 Mn |
| Dec 31, 2021 | 30.00 Mn |
| Sep 30, 2021 | 34.00 Mn |